Role of Interleukin-17 in Acute Pancreatitis

Front Immunol. 2021 Sep 14:12:674803. doi: 10.3389/fimmu.2021.674803. eCollection 2021.

Abstract

Acute pancreatitis (AP) is a leading cause of death and is commonly accompanied by systemic manifestations that are generally associated with a poor prognosis. Many cytokines contribute to pancreatic tissue damage and cause systemic injury. Interleukin-17 (IL-17) is a cytokine that may play a vital role in AP. Specifically, IL-17 has important effects on the immune response and causes interactions between different inflammatory mediators in the AP-related microenvironment. In this literature review, we will discuss the existing academic understanding of IL-17 and the impacts of IL-17 in different cells (especially in acinar cells and immune system cells) in AP pathogenesis. The clinical significance and potential mechanisms of IL-17 on AP deterioration are emphasized. The evidence suggests that inhibiting the IL-17 cytokine family could alleviate the pathogenic process of AP, and we highlight therapeutic strategies that directly or indirectly target IL-17 cytokines in acute pancreatitis.

Keywords: T helper 17 cells; acute pancreatitis; gut microbiome; immune response; interleukin-17.

Publication types

  • Research Support, Non-U.S. Gov't
  • Review

MeSH terms

  • Animals
  • Disease Models, Animal
  • Gastrointestinal Microbiome / immunology
  • Humans
  • Immunity*
  • Interleukin-17 / antagonists & inhibitors
  • Interleukin-17 / blood*
  • Mice
  • Molecular Targeted Therapy / methods
  • Pancreatitis / drug therapy
  • Pancreatitis / epidemiology*
  • Pancreatitis / immunology*
  • Risk Factors
  • Th17 Cells / immunology
  • Treatment Outcome

Substances

  • IL17A protein, human
  • Il17a protein, mouse
  • Interleukin-17